/Companies

Quibim

Founded 2015 · 116 employees on LinkedIn · 17 known investors

Find your way into Quibim

Sign up to see every warm intro you have to Quibim

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Quibim team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Quibim develops cloud-based AI software platforms for medical imaging analysis that extract radiomics features and generate predictive models for healthcare providers and biopharma companies. The company offers modular products for prostate, brain, liver, and breast MRI analysis, plus a data management platform for clinical research and drug development programs.

Investors · 17

Also in the syndicate · 5

BuenavistaBuild CollectiveCDTI InnovaciónColumbusUI Investissements

Funding

SEC filings, press & company announcements

$50M disclosed across 1 of 2 rounds · 2025

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 1

Companies working in the same space as Quibim.

In the news

Frequently asked questions

What does Quibim do?
Quibim develops cloud-based AI software platforms for medical imaging analysis that extract radiomics features and generate predictive models for healthcare providers and biopharma companies. The company offers modular products for prostate, brain, liver, and breast MRI analysis, plus a data management platform for clinical research and drug development programs.
Who are Quibim's investors?
Quibim's investors include Adara Ventures, Amadeus Capital Partners, APEX Ventures, Asabys Partners, LifeX Ventures, Partech Ventures, Angels Capital, Cambridge Innovation Capital and 4 more.
How much funding has Quibim raised?
Quibim has disclosed $50M raised across 1 of its 2 known rounds.